NCT02797613

Brief Summary

Asymptomatic bacteriuria (AB) is a condition in which bacteria are detected in urine culture without urinary symptoms. The inappropriate use of antibiotic treatment for AB selects bacterial flora to express resistance mutations. Reducing inappropriate antibiotic use for AB is difficult, since the microbiology laboratory cannot distinguish patients with AB. The investigators study will use a restricted laboratory report requesting the physician to call the laboratory for culture results. The restricted report may reduce the rate of inappropriate treatment of AB.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 13, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 27, 2020

Completed
Last Updated

February 27, 2020

Status Verified

February 1, 2020

Enrollment Period

4 months

First QC Date

June 8, 2016

Results QC Date

March 5, 2019

Last Update Submit

February 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Number of Patients Receiving Appropriate Treatment

    Sum of urinary tract infection treated and asymptomatic bacteriuria not treated

    72 hours from positive culture

Study Arms (2)

Restricted Reporting

EXPERIMENTAL

Microbiology laboratory will report "Positive urine cultures may represent asymptomatic bacteriuria or urinary tract infection. If urinary tract infection is suspected clinically, please call 777-xxxx (researcher mobile phone) for identification and susceptibility results"

Behavioral: Restricted Reporting

Standard Reporting

NO INTERVENTION

Microbiology laboratory will report identification and susceptibility results

Interventions

An abbreviated version of the microbiology report indicating that growth is present and the physician should call the lab for further details if clinically important

Restricted Reporting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • positive urine culture from inpatients at Health Sciences Centre or St. Clare's Mercy Hospital or outpatients during study period.

You may not qualify if:

  • pregnancy,
  • antibiotic treatment at the time of urine collection,
  • collection from an indwelling catheter,
  • admission to long term care facility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences Center

St. John's, Newfoundland and Labrador, A1B3V6, Canada

Location

Related Publications (1)

  • Daley P, Garcia D, Inayatullah R, Penney C, Boyd S. Modified Reporting of Positive Urine Cultures to Reduce Inappropriate Treatment of Asymptomatic Bacteriuria Among Nonpregnant, Noncatheterized Inpatients: A Randomized Controlled Trial. Infect Control Hosp Epidemiol. 2018 Jul;39(7):814-819. doi: 10.1017/ice.2018.100. Epub 2018 May 28.

MeSH Terms

Conditions

BacteriuriaUrinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Limitations and Caveats

Our design is a proof-of-concept which will require additional trials to verify. It would be impractical to manually screen all inpatient urine specimens using our inclusion criteria, although automated eligibility screening may be possible.

Results Point of Contact

Title
Peter Daley
Organization
Memorial University

Study Officials

  • Peter Daley, MD FRCPC

    Memorial University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 8, 2016

First Posted

June 13, 2016

Study Start

January 1, 2017

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

February 27, 2020

Results First Posted

February 27, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations